12:00 AM
 | 
Jan 30, 2014
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cancer
Breast cancer; colon cancer Programmed cell death 1 ligand 1 (CD274 molecule; PD-L1; B7-H1) Mouse studies suggest PD-L1 inhibitors could...

Read the full 262 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >